Skip to main content
. 2013 Oct 11;288(48):34470–34483. doi: 10.1074/jbc.M113.515668

TABLE 2.

Summary of functional assays in the tested mutants

A cAMP inhibition assay was used to measure the potencies (pEC50 ± S.E.) of the tested ligands at the different mutants (n = 3–5). ND, not determined.

KOR variant Salvinorin A U-96593 Dynorphin A(1–17) 1xx
WT 9.87 ± 0.05 8.49 ± 0.08 8.32 ± 0.06 7.29 ± 0.09
Y66A (1.38) 9.01 ± 0.05 7.75 ± 0.05 7.98 ± 0.06 6.81 ± 0.04
Q115A (2.60) 8.58 ± 0.05 8.5 ± 0.04 7.19 ± 0.06 7.14 ± 0.05
Y119A (2.64) 8.41 ± 0.04 8.04 ± 0.05 7.26 ± 0.06 6.23 ± 0.04
Y119F (2.64) 9.28 ± 0.03 8.09 ± 0.06 8.42 ± 0.04 6.86 ± 0.04
I135A (3.29) 8.06 ± 0.04 7.14 ± 0.04 7.67 ± 0.04 5.78 ± 0.05
D138A (3.32) 9.6 ± 0.13 ND ND 7.44 ± 0.09
D138N (3.32) 10.6 ± 0.03 5.16 ± 0.25 5.72 ± 0.05 8.04 ± 0.05
Y139A (3.33) 8.14 ± 0.05 7.55 ± 0.07 6.93 ± 0.04 6.4 ± 0.07
Y139F (3.33) 9.72 ± 0.04 8.48 ± 0.04 7.65 ± 0.06 6.86 ± 0.05
M142A (3.36) 7.77 ± 0.04 7.71 ± 0.04 6.97 ± 0.05 7.55 ± 0.04
K200A (ECL2) 10.03 ± 0.03 8.9 ± 0.03 8.8 ± 0.03 7.1 ± 0.03
L212A (ECL2) 8.21 ± 0.04 7.78 ± 0.04 7.1 ± 0.04 5.88 ± 0.04
M226A (5.38) 10.43 ± 0.05 9.73 ± 0.05 8.86 ± 0.05 7.37 ± 0.05
K227A (5.39) 9.29 ± 0.03 8.38 ± 0.03 7.93 ± 0.06 6.65 ± 0.07
H291A (6.52) 8.14 ± 0.06 6.87 ± 0.06 6.58 ± 0.07 6.05 ± 0.08
H291F (6.52) 8.79 ± 0.04 8.37 ± 0.04 7.09 ± 0.04 6.64 ± 0.04
I294A (6.55) 10.06 ± 0.06 8.33 ± 0.08 7.14 ± 0.05 6.46 ± 0.07
E297A (6.58) 9.93 ± 0.03 8.93 ± 0.04 7.36 ± 0.04 7.19 ± 0.04
Y312A (7.35) 8.21 ± 0.04 7.19 ± 0.03 7.33 ± 0.04 6.44 ± 0.05
Y312F (7.35) 9.56 ± 0.03 8.25 ± 0.04 8.24 ± 0.04 7.15 ± 0.05
Y313A (7.36) 8.05 ± 0.04 8.38 ± 0.05 7.52 ± 0.04 6.49 ± 0.06
Y313F (7.36) 9.55 ± 0.04 8.32 ± 0.03 8.23 ± 0.06 7.24 ± 0.07
I316A (7.39) 6.6 ± 0.11 7.72 ± 0.05 6.9 ± 0.05 6.4 ± 0.04
Y320A (7.43) 6.45 ± 0.05 6.08 ± 0.1 7 ± 0.08 ND
Y320F (7.43) 7.67 ± 0.05 6.81 ± 0.05 7.12 ± 0.04 6.6 ± 0.07